➤ Get the DrugPatentWatch Daily Briefing

Get Daily Updates on Generic Entry, Litigation, Biosimilars, and more …

Serving leading biopharmaceutical companies globally:

McKinsey
Dow
Boehringer Ingelheim
Moodys
Harvard Business School
Medtronic

Last Updated: May 14, 2021

DrugPatentWatch Database Preview

SODIUM POLYSTYRENE SULFONATE Drug Profile

➤ Get the DrugPatentWatch Daily Briefing
» See Plans and Pricing

« Back to Dashboard

When do Sodium Polystyrene Sulfonate patents expire, and when can generic versions of Sodium Polystyrene Sulfonate launch?

Sodium Polystyrene Sulfonate is a drug marketed by Belcher, Citrusphrma, Cmp Pharma Inc, Discovery Therap, Epic Pharma Llc, Novelgenix Theraps, Nuvo Pharms Inc, Wockhardt, Ani Pharms Inc, Hikma, Morton Grove, and Roxane. and is included in twelve NDAs.

The generic ingredient in SODIUM POLYSTYRENE SULFONATE is sodium polystyrene sulfonate. There are one thousand four hundred and seventy-two drug master file entries for this compound. Twelve suppliers are listed for this compound. Additional details are available on the sodium polystyrene sulfonate profile page.

Drug patent expirations by year for SODIUM POLYSTYRENE SULFONATE
Drug Prices for SODIUM POLYSTYRENE SULFONATE

See drug prices for SODIUM POLYSTYRENE SULFONATE

Recent Clinical Trials for SODIUM POLYSTYRENE SULFONATE

Identify potential brand extensions & 505(b)(2) entrants

SponsorPhase
University of California, IrvinePhase 4
Tris Pharma, Inc.Phase 4
Weill Medical College of Cornell UniversityPhase 4

See all SODIUM POLYSTYRENE SULFONATE clinical trials

US Patents and Regulatory Information for SODIUM POLYSTYRENE SULFONATE

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Belcher SODIUM POLYSTYRENE SULFONATE sodium polystyrene sulfonate POWDER;ORAL, RECTAL 205727-001 Feb 23, 2016 AA RX No No   Get Started for $10   Get Started for $10   Get Started for $10
Nuvo Pharms Inc SODIUM POLYSTYRENE SULFONATE sodium polystyrene sulfonate POWDER;ORAL, RECTAL 204071-002 Nov 28, 2014 RX No No   Get Started for $10   Get Started for $10   Get Started for $10
Discovery Therap SODIUM POLYSTYRENE SULFONATE sodium polystyrene sulfonate POWDER;ORAL, RECTAL 090313-001 Dec 21, 2011 AA RX No No   Get Started for $10   Get Started for $10   Get Started for $10
>Applicant >Tradename >Generic Name >Dosage >NDA >Approval Date >TE >Type >RLD >RS >Patent No. >Patent Expiration >Product >Substance >Delist Req. >Exclusivity Expiration

Make Better Decisions: Try a trial or see plans & pricing

Serving leading biopharmaceutical companies globally:

Mallinckrodt
Moodys
Harvard Business School
Merck
Boehringer Ingelheim
AstraZeneca

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.